[1]
“Evaluation of Post-Bronchodilator Reversibility in Patient with Chronic Obstructive Pulmonary Disease and Asthma”, Nep. Med. Coll. J., vol. 22, no. 4, pp. 223–227, Dec. 2020, doi: 10.3126/nmcj.v22i4.34185.